Media Summary: For many pharmaceutical and biotech companies entering preclinical and clinical studies, their Multiple considerations have to be made during the FDA/M-CERSI The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance Workshop (April 30-May 1, 2026) ...
Web Lecture Series 5 Formulation Development And Challenges - Detailed Analysis & Overview
For many pharmaceutical and biotech companies entering preclinical and clinical studies, their Multiple considerations have to be made during the FDA/M-CERSI The Evolution of Biopharmaceutics: Risk Assessment and Clinical Relevance Workshop (April 30-May 1, 2026) ... Moderated by Jennifer Chu, Ph.D., FreeThink Technologies